Package 0591-4385-79

{"route": ["INTRAVENOUS"], "spl_id": "89783971-3346-4ff8-ac47-d824a7ddf75d", "openfda": {"upc": ["0305914385794"], "unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["9dbd4c29-d894-4839-9b22-a2f65c8c8ad1"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0591-4385-79)", "package_ndc": "0591-4385-79", "marketing_start_date": "20190919"}], "brand_name": "Fosaprepitant", "product_id": "0591-4385_89783971-3346-4ff8-ac47-d824a7ddf75d", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "0591-4385", "generic_name": "fosaprepitant", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosaprepitant", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/1"}], "application_number": "NDA210064", "marketing_category": "NDA", "marketing_start_date": "20190919", "listing_expiration_date": "20261231"}